Randox Food Diagnostics has announced the release of an Anthelmintics testing platform (EV3770). This multi-analyte testing array is used in conjunction with the patented Randox Biochip Array Technology and Evidence Investigator analyzer.
The extensive test menu includes Avermectins, Benzimidazoles, Amino–benzimidazoles, Levamisole, Thiabendazole, Moxidectin and Triclabendazole.
Anthelmintics are drugs that act against internal parasites of animals such as tapeworms, liver flukes and round worms that can cause helminthic infections.
The use of Anthelmintic drugs can greatly improve livestock production; however, effective monitoring is required to ensure residues are not passed into the human food chain.
Due to the excellent generic nature of our in house developed antibodies, the Anthelmintics Array can detect 25 analytes in total. Both parent and metabolite forms of the most commonly abused anthelmintic compounds can be detected.
These include albendazole sulphoxide and albendazole - 2 aminosulphones that are the main residues detected in tissue matrices irrespective of whether animals were dosed with netobimim, albendazole or albendazole sulphoxide.
The generic Avermectin biochip can detect residues of Ivermectin, Abamectin, Doramectin, Emamectin benzoate and Eprimomectin, all or some of which have been noted as marker residues in food by the European Union, CODEX, Canada and the United States of America.
Excellent limits of detection are achieved in milk (0.05 - 3ppb) and in beef muscle (0.15 - 6.5ppb) ensuring compliance with most regulatory tolerance requirements is achieved.